BioSpace News Archive

Business

Tom Polen Promoted to Chief Operating Officer of BD

BD today announced that Tom Polen will add the responsibility of chief operating officer of BD, in addition to his current role as president.

October 3, 2018
·
2 min read
Biotech Bay

Anpac Bio & UCD Vet Med in Clinical Trial Studying ‘CDA’ Liquid Biopsy Tech for Canine Cancer Screening

Technical Advisory Board Member John Reddington, DVM, PhD & Biosciences Leader to Support New Anpac Bio Animal Care R&D

October 3, 2018
·
4 min read
Business

Vineti Appoints Christophe Suchet as Chief Product Officer

With cell and gene expertise in high demand, industry innovator will help expand the leading cloud-based software “platform of record”...

October 3, 2018
·
4 min read
Biotech Bay

SI-BONE, Inc. Announces that NICE, the UK National Institute for Health and Care Excellence, Published Medical Technology Guidance Finding that the Evidence Supports Treatment of Sacroiliac Joint Pain with the iFuse Implant System®

The recommendation, unique to iFuse among sacroiliac joint fusion devices, concludes that using iFuse leads to improved pain relief, better quality of life and less disability compared to non-surgical management

October 3, 2018
·
3 min read
Business

Centre for Probe Development & Commercialization (CPDC) Appoints New CEO and President

CPDC has appointed Dr. Joe McCann, CPDC’s current Chief Operating Officer, as its new CEO and President, effective immediately.

October 3, 2018
·
3 min read
Pharm Country

National MS Society Commits $12 Million to 40 New Research Projects to Stop Multiple Sclerosis, Restore Function and End MS Forever

A cutting-edge treatment for fatigue, strategies to repair myelin, and MS risk factor candidates are among the new leads being explored

October 3, 2018
·
2 min read
Drug Development

Seres Therapeutics to Present New Data Supporting SER-109 Clinical Activity at IDWeek 2018

Findings support SER-109 Phase 3 program as a potential new treatment option for C. difficile infection

October 3, 2018
·
5 min read
Business

Eagle Pharmaceuticals Enters into Agreement with USAMRICD to Evaluate Neuroprotective Effects of RYANODEX Secondary to Nerve Agent Exposure

The study will be conducted under a Cooperative Research and Development Agreement

October 3, 2018
·
5 min read
Drug Development

Alnylam Submits Clinical Trial Authorization (CTA) Application for ALN-AAT02, an Investigational RNAi Therapeutic for the Treatment of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease (Alpha-1 Liver Disease)

ALN-AAT02 is the First Investigational RNAi Therapeutic to Utilize Alnylam’s Enhanced Stabilization Chemistry Plus (ESC+) GalNAc-Conjugate Technology

October 3, 2018
·
8 min read
FDA

Therapure Biomanufacturing Announces U.S. FDA Approval for Manufacturing of Its Partner Insmed’s ARIKAYCE®

FDA granted accelerated approval for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients who have limited or no alternative treatment options.

October 3, 2018
·
3 min read